David S. Ege - Executive Vice President and Chief Technology Officer at Seres Therapeutics, Inc.

Issuer-level insider activity

Role: Executive Vice President and Chief Technology Officer
Issuer ticker: MCRB on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by David S. Ege since 21 Oct 2025

Reported holdings for David S. Ege in Seres Therapeutics, Inc.

Form 4 holding Executive Vice President and Chief Technology Officer

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 77,575
Estimated value: $65,163
Report date: 16 Aug 2024
Price: $0.8400
Ownership: Direct

Form 4 holding Executive Vice President and Chief Technology Officer

Seres Therapeutics, Inc.

Security class: Restricted Stock Units
Shares / value: 29,688
Estimated value: $32,179
Report date: 15 Aug 2024
Price: $1.08
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Executive Vice President and Chief Technology Officer

Seres Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 287,905
Estimated value
Report date: 14 Feb 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for David S. Ege in Seres Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .